Cidara Therapeutics (NASDAQ:CDTX) filed a prospectus related to the offer and resale of up to about 7.04 million shares of common stocks. This prospectus is not an offer to sell. The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. Filing
More on Cidara Therapeutics
Seeking Alpha's Quant Rating on Cidara Therapeutics Historical earnings data for Cidara Therapeutics Financial information for Cidara Therapeutics